Status:
TERMINATED
Islet of Langerhans Graft Monitoring by Magnetic Resonance Imaging
Lead Sponsor:
University Hospital, Geneva
Conditions:
Type 1 Diabetes Mellitus
Eligibility:
All Genders
18-65 years
Phase:
PHASE1
Brief Summary
The primary objective of this pilot study is to assess the feasibility and safety of ex vivo islet labelling prior to intraportal transplantation in patients with type 1 diabetes with the purpose of i...
Detailed Description
The objectives will be addressed in a pilot study. We plan to enroll 15 patients over 3 years in islet transplantation alone (ITA), islet-after-kidney transplantation (IAK) or simultaneous islet-kidne...
Eligibility Criteria
Inclusion
- All patients on the waiting list for an islet of Langerhans transplantation procedure
Exclusion
- Allergy to ferucarbotran
- Inability to undergo MRI (patients carrying osteosynthesis material, pacemakers or other metallic devices)
- Claustrophobia (tolerance to MRI)
- Hemosiderosis/hemochromatosis (interference with MRI signal)
Key Trial Info
Start Date :
June 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2010
Estimated Enrollment :
5 Patients enrolled
Trial Details
Trial ID
NCT00453817
Start Date
June 1 2005
End Date
June 1 2010
Last Update
December 2 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Geneva University Hospitals Department of Surgery
Geneva, Switzerland, 1211